drugset / Trial / NCT00874601

Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke

NCT00874601

Phase 4 Unknown 578 enrolled Hallym University Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The manipulation of blood pressure in acute cerebral ischemia has been a matter of debate until now. The investigators are clearly in need of more detailed data on how antihypertensive treatment affects outcome in acute phase of stroke. This study will assess the effects of modest blood pressure (BP) lowering manipulation in acute period of ischemic stroke on death or dependency at 90-day.

Timeline

Start
2008-10
Primary completion
2011-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Valsartan Small molecule 80 mg Oral
Subject Valsartan Small molecule 320 mg Oral

Indications